# Rationale and methodology of a multicentric prospective cohort study on ‘Longitudinal Effects of Air Pollution Exposure on Adolescent Lungs (APEAL)’ in urban India: APEAL protocol

**Authors:** Twinkle Agrawal, Harish C Phuleria, Anant Mohan, George D’Souza, Rajesh Thimmulappa, Biligere Siddaiah Jayaraj, Minu Rose Mani, Swapnali Patil, Priya Samdarshi, Amruta Nori-Sarma, Gregory Wellenius, Padukudru Anand Mahesh

PMC · DOI: 10.1136/bmjopen-2025-106329 · BMJ Open · 2025-08-12

## TL;DR

This study investigates how air pollution affects lung development in Indian children by tracking lung function and biomarkers in cities with varying pollution levels.

## Contribution

The study introduces a large-scale, multi-city cohort in urban India to assess long-term air pollution effects on children's lung health.

## Key findings

- Children in highly polluted cities may show higher rates of reduced lung function.
- The study aims to establish age-appropriate lung function reference values for Indian urban children.
- Biomarkers could help identify children at risk of pollution-induced lung impairment.

## Abstract

Air pollution is a significant global health concern, with studies from the USA and Europe linking long-term exposure to respiratory issues and poor school attendance in children. While Indian cities experience much higher pollution levels, the impact on lung development in Indian children remains unclear. This study aims to assess the burden of impaired lung function in Indian children and identify key factors contributing to pollution-induced lung injury.

This longitudinal, prospective cohort study is conducted in four cities categorised by particulate matter 2.5 (PM2.5) levels: ‘very high’ (Delhi), ‘high’ (Mumbai, Bangalore) and ‘moderate’ (Mysore). A total of 4000 participants (1000 from each city) will be included in the study. Participants will complete a structured questionnaire covering sociodemographics, asthma and allergy history (International Study of Asthma and Allergies in Childhood core questionnaire), dietary intake (24-hour recall and Food Frequency Questionnaire), Physical Activity-C Questionnaire and air pollution exposure. Spirometry and Forced Oscillation Technique will be used to assess lung function. Blood samples will be collected for identification of biomarkers to predict lung impairment. After quality checks, data will be compiled, summarising pulmonary function parameters alongside covariates and confounders. Analysis of Variance (ANOVA) will assess between-city and within-city differences in lung function.

We anticipate a higher prevalence of reduced lung function in children residing in cities with very high and high PM2.5 levels compared with the moderately polluted city. Findings from this study could establish normal age-appropriate lung function reference values for Indian urban children, aiding in clinical diagnosis.If a reliable biomarker for identifying children at risk of lung impairment is available, it could serve as an early predictor of poor lung health in asymptomatic children.

The approval from individual site institutional review board (IRB) is obtained prior to initiation of the study from institutional ethics committee, St. John’s Medical College and Hospital, Bangalore; institutional ethics committee, JSS Medical College, Mysore; institute ethics committee, Indian Institute of Technology Bombay and institute ethics committee, All India Institute of Medical Sciences. Findings from this study will be disseminated through conference presentations, peer-reviewed publications and establishment of normal age-appropriate lung function reference values for children living in urban India.

## Linked entities

- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SCGB1A1 (secretoglobin family 1A member 1) [NCBI Gene 7356] {aka CC10, CC16, CCPBP, CCSP, UGB, UP-1}
- **Diseases:** chest wall deformities (MESH:D013898), cardiac illness (MESH:D006331), eczema (MESH:D004485), lung damage (MESH:D008171), vitamin deficiencies (MESH:D014802), Asthma (MESH:D001249), impaired lung function (MESH:D003072), lung impairment (MESH:D009422), allergy (MESH:D004342), respiratory disease (MESH:D012140), deaths (MESH:D003643), BOLD (MESH:D008173), inflammation (MESH:D007249), wheezing (MESH:D012135), non-communicable diseases (MESH:D000073296), COPD (MESH:D029424), respiratory infections (MESH:D012141), rhinitis (MESH:D012220), low lung function (MESH:D055370), COVID (MESH:D000086382), tuberculosis (MESH:D014376), reduced lung function (MESH:D001523)
- **Chemicals:** O3 (MESH:D010126), polycyclic aromatic hydrocarbons (MESH:D011084), SO2 (MESH:D013458), NO2 (MESH:D009585), carbon monoxide (MESH:D002248), PM2.5 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12352163/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12352163/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12352163/full.md

---
Source: https://tomesphere.com/paper/PMC12352163